Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
247.76
-8.76 (-3.41%)
Aug 11, 2026, 12:05 PM EDT - Market open

Jazz Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
16,08310,4447,4677,65710,0717,852
Market Cap Growth
138.22%39.87%-2.49%-23.96%28.26%-15.31%
Enterprise Value
18,29313,41110,62111,80314,98513,398
Last Close Price
247.76170.00123.15123.00159.31127.40
PE Ratio
17.53-14.2420.16--
Forward PE
10.147.675.726.298.548.23
PEG Ratio
0.190.550.370.501.140.62
PS Ratio
3.512.451.842.002.752.54
PB Ratio
3.462.421.822.053.261.98
P/FCF Ratio
10.148.055.507.178.1010.46
P/OCF Ratio
9.717.705.357.017.9210.09
EV/Sales Ratio
3.993.142.613.084.104.33
EV/EBITDA Ratio
11.3650.417.729.7026.5718.54
EV/EBIT Ratio
20.45-14.8220.40-78.68
EV/FCF Ratio
11.5310.347.8211.0512.0617.84
Debt / Equity Ratio
0.701.011.491.381.871.54
Debt / EBITDA Ratio
2.7220.334.474.7410.288.49
Debt / FCF Ratio
2.764.174.535.404.668.17
Net Debt / Equity Ratio
0.460.690.771.111.591.40
Net Debt / EBITDA Ratio
1.3611.152.293.418.727.67
Net Debt / FCF Ratio
1.382.292.323.883.957.39
Asset Turnover
0.400.360.350.340.320.33
Inventory Turnover
1.241.120.830.660.610.78
Quick Ratio
1.381.463.571.521.641.43
Current Ratio
1.781.864.462.242.793.23
Return on Equity (ROE)
20.63%-8.45%14.35%12.25%-6.07%-8.63%
Return on Assets (ROA)
10.20%-2.06%7.31%7.30%-0.33%5.27%
Return on Invested Capital (ROIC)
16.50%-3.35%11.31%10.22%-0.43%7.12%
Return on Capital Employed (ROCE)
9.82%-4.22%6.88%5.86%-0.61%1.96%
Earnings Yield
5.83%-7.02%4.96%--
FCF Yield
9.86%12.42%18.19%13.95%12.34%9.56%
Buyback Yield / Dilution
-5.40%7.61%8.41%-15.23%-4.77%-5.62%
Total Shareholder Return
-5.40%7.61%8.41%-15.23%-4.77%-5.62%
SEC Filings: 10-K · 10-Q